Please assess the completion status of the following clinical trial:

Trial Title: Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult between 18 years and above~* Moderate to severe disease activity~* Negative pregnancy test for women of childbearing potential~* Use of reliable method of contraception (non-hormonal) by sexually active female patients~Exclusion Criteria:~* Patients who are pregnant or breastfeeding~* Patients taking biologic therapy or prednisolone \>7.5mg

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Cetrorelix
- 2 (Type: PLACEBO_COMPARATOR): NaCl solution

Based on this trial design, predict the completion outcome and termination type (if applicable).